These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Soluble MHC I and soluble MIC molecules: potential therapeutic targets for cancer.
    Author: Zhao J, Guo Y, Yan Z, Zhang J, Bushkin Y, Liang P.
    Journal: Int Rev Immunol; 2011 Feb; 30(1):35-43. PubMed ID: 21235324.
    Abstract:
    It has become clear that soluble MHC I (sMHC I) and soluble MIC (sMIC), which are highly elevated in sera of cancer patients, can be viewed to be tolerogenic, and that metalloproteinases are involved in their generation process. In this review, an overview is provided of the recent progress made in the sMHC I and sMIC fields, with emphasis on their structure, formation, and function, and the key-questions that still await answers are addressed. Understanding better their formation mechanism, it will become more feasible to modulate the immune responses in cancer patients by targeting molecules involved in their generation process.
    [Abstract] [Full Text] [Related] [New Search]